Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Faeth Therapeutics, Inc. Filed Acc 0001493152-26-052839

Stakes reported in this filing

Reporting person Shares Of the class
Trails Edge Capital Partners, LP 1,385,878 5.4%
Trails Edge Biotechnology Master Fund, LP 1,385,878 5.4%
Ortav Yehudai 1,385,878 5.4%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…